Artículos de revistas sobre el tema "BST2/Tetherin"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 49 mejores artículos de revistas para su investigación sobre el tema "BST2/Tetherin".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ooi, Yaw, Mathieu Dubé y Margaret Kielian. "BST2/Tetherin Inhibition of Alphavirus Exit". Viruses 7, n.º 4 (22 de abril de 2015): 2147–67. http://dx.doi.org/10.3390/v7042147.
Texto completoViswanathan, Kasinath, M. Shane Smith, Daniel Malouli, Mandana Mansouri, Jay A. Nelson y Klaus Früh. "BST2/Tetherin Enhances Entry of Human Cytomegalovirus". PLoS Pathogens 7, n.º 11 (3 de noviembre de 2011): e1002332. http://dx.doi.org/10.1371/journal.ppat.1002332.
Texto completoShi, Yuhang, Sydney Simpson, Yuexuan Chen, Haley Aull, Jared Benjamin y Ruth Serra-Moreno. "Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin". PLOS Pathogens 20, n.º 1 (8 de enero de 2024): e1011912. http://dx.doi.org/10.1371/journal.ppat.1011912.
Texto completoZheng, Yun, Xiangqi Hao, Qingxu Zheng, Xi Lin, Xin Zhang, Weijie Zeng, Shiyue Ding, Pei Zhou y Shoujun Li. "Canine Influenza Virus is Mildly Restricted by Canine Tetherin Protein". Viruses 10, n.º 10 (16 de octubre de 2018): 565. http://dx.doi.org/10.3390/v10100565.
Texto completoMansouri, Mandana, Kasinath Viswanathan, Janet L. Douglas, Jennie Hines, Jean Gustin, Ashlee V. Moses y Klaus Früh. "Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus". Journal of Virology 83, n.º 19 (15 de julio de 2009): 9672–81. http://dx.doi.org/10.1128/jvi.00597-09.
Texto completoKelly, James T., Stacey Human, Joseph Alderman, Fatoumatta Jobe, Leanne Logan, Thomas Rix, Daniel Gonçalves-Carneiro et al. "BST2/Tetherin Overexpression Modulates Morbillivirus Glycoprotein Production to Inhibit Cell–Cell Fusion". Viruses 11, n.º 8 (30 de julio de 2019): 692. http://dx.doi.org/10.3390/v11080692.
Texto completoZhao, Xiaojuan, Dominic Alibhai, Ting Sun, Jawad Khalil, James L. Hutchinson, Kaya Olzak, Christopher M. Williams et al. "Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling". Blood Advances 5, n.º 7 (1 de abril de 2021): 1884–98. http://dx.doi.org/10.1182/bloodadvances.2020003182.
Texto completoMiller, Katelyn D., Christine Matullo, Riley Williams, Carli B. Jones y Glenn F. Rall. "Murine BST2/tetherin promotes measles virus infection of neurons". Virology 563 (noviembre de 2021): 38–43. http://dx.doi.org/10.1016/j.virol.2021.08.005.
Texto completoDietrich, Isabelle, Margaret J. Hosie y Brian J. Willett. "The role of BST2/tetherin in feline retrovirus infection". Veterinary Immunology and Immunopathology 143, n.º 3-4 (octubre de 2011): 255–64. http://dx.doi.org/10.1016/j.vetimm.2011.06.020.
Texto completoVigan, Raphaël y Stuart J. D. Neil. "Determinants of Tetherin Antagonism in the Transmembrane Domain of the Human Immunodeficiency Virus Type 1 Vpu Protein". Journal of Virology 84, n.º 24 (6 de octubre de 2010): 12958–70. http://dx.doi.org/10.1128/jvi.01699-10.
Texto completoPetit, Sarah J., Caroline Blondeau y Greg J. Towers. "Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin". Journal of General Virology 92, n.º 12 (1 de diciembre de 2011): 2937–48. http://dx.doi.org/10.1099/vir.0.035931-0.
Texto completoSneha, Patil, Urmi Shah y Seetharaman Balaji. "In Silico Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts". Medical Sciences 7, n.º 6 (22 de junio de 2019): 74. http://dx.doi.org/10.3390/medsci7060074.
Texto completoArnaud, Frederick, Sarah G. Black, Lita Murphy, David J. Griffiths, Stuart J. Neil, Thomas E. Spencer y Massimo Palmarini. "Interplay between Ovine Bone Marrow Stromal Cell Antigen 2/Tetherin and Endogenous Retroviruses". Journal of Virology 84, n.º 9 (24 de febrero de 2010): 4415–25. http://dx.doi.org/10.1128/jvi.00029-10.
Texto completoPan, Xiao-Ben, Jin-Chao Han, Xu Cong y Lai Wei. "BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells". PLoS ONE 7, n.º 12 (7 de diciembre de 2012): e51033. http://dx.doi.org/10.1371/journal.pone.0051033.
Texto completoHolmgren, Alicia M., Katelyn D. Miller, Sarah E. Cavanaugh y Glenn F. Rall. "Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge". Journal of Virology 89, n.º 21 (26 de agosto de 2015): 11011–18. http://dx.doi.org/10.1128/jvi.01745-15.
Texto completoPetrosino, Maria, Francesco Stellato, Roberta Chiaraluce, Valerio Consalvi, Giovanni La Penna, Alessandra Pasquo, Olivier Proux, Giancarlo Rossi y Silvia Morante. "Zn‐Induced Interactions Between SARS‐CoV‐2 orf7a and BST2/Tetherin". ChemistryOpen 10, n.º 11 (noviembre de 2021): 1133–41. http://dx.doi.org/10.1002/open.202100217.
Texto completoPan, Xiao-Ben, Xiao-Wang Qu, Dong Jiang, Xing-Liang Zhao, Jin-Chao Han y Lai Wei. "BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells". Antiviral Research 98, n.º 1 (abril de 2013): 54–60. http://dx.doi.org/10.1016/j.antiviral.2013.01.009.
Texto completoBego, Mariana G., Lijun Cong, Katharina Mack, Frank Kirchhoff y Éric A. Cohen. "Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains". Journal of Virology 90, n.º 22 (31 de agosto de 2016): 10236–46. http://dx.doi.org/10.1128/jvi.01131-16.
Texto completoStrauss, Joshua D., Jason E. Hammonds, Hong Yi, Lingmei Ding, Paul Spearman y Elizabeth R. Wright. "Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells". Journal of Virology 90, n.º 3 (18 de noviembre de 2015): 1507–21. http://dx.doi.org/10.1128/jvi.01880-15.
Texto completoPan, X. B., J. H. Chang, T. M. Block y J. T. Guo. "PP-145 BST2/Tetherin inhibits hepatitis C virus release from human hepatoma cells". International Journal of Infectious Diseases 15 (julio de 2011): S85—S86. http://dx.doi.org/10.1016/s1201-9712(11)60297-x.
Texto completoPresle, Adrien, Stéphane Frémont, Audrey Salles, Pierre-Henri Commere, Nathalie Sassoon, Clarisse Berlioz-Torrent, Neetu Gupta-Rossi y Arnaud Echard. "The viral restriction factor tetherin/BST2 tethers cytokinetic midbody remnants to the cell surface". Current Biology 31, n.º 10 (mayo de 2021): 2203–13. http://dx.doi.org/10.1016/j.cub.2021.02.039.
Texto completoSauter, Daniel, Michael Vogl y Frank Kirchhoff. "Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses". Human Mutation 32, n.º 11 (11 de agosto de 2011): 1243–45. http://dx.doi.org/10.1002/humu.21571.
Texto completoJanvier, Katy, Nicolas Roy y Clarisse Berlioz-Torrent. "Role of the Endosomal ESCRT Machinery in HIV-1 Vpu-Induced Down- Regulation of BST2/Tetherin". Current HIV Research 10, n.º 4 (1 de mayo de 2012): 315–20. http://dx.doi.org/10.2174/157016212800792414.
Texto completoSwiecki, Melissa, Yaming Wang, Susan Gilfillan, Deborah J. Lenschow y Marco Colonna. "Cutting Edge: Paradoxical Roles of BST2/Tetherin in Promoting Type I IFN Response and Viral Infection". Journal of Immunology 188, n.º 6 (10 de febrero de 2012): 2488–92. http://dx.doi.org/10.4049/jimmunol.1103145.
Texto completoSchubert, H. L., Q. Zhai, V. Sandrin, D. M. Eckert, M. Garcia-Maya, L. Saul, W. I. Sundquist, R. A. Steiner y C. P. Hill. "Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations". Proceedings of the National Academy of Sciences 107, n.º 42 (29 de septiembre de 2010): 17951–56. http://dx.doi.org/10.1073/pnas.1008206107.
Texto completoJia, Bin, Ruth Serra-Moreno, William Neidermyer, Andrew Rahmberg, John Mackey, Ismael Ben Fofana, Welkin E. Johnson, Susan Westmoreland y David T. Evans. "Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2". PLoS Pathogens 5, n.º 5 (15 de mayo de 2009): e1000429. http://dx.doi.org/10.1371/journal.ppat.1000429.
Texto completoEpeldegui, Marta, Bianca Blom y Christel H. Uittenbogaart. "BST2/Tetherin is constitutively expressed on human thymocytes with the phenotype and function of Treg cells". European Journal of Immunology 45, n.º 3 (16 de diciembre de 2014): 728–37. http://dx.doi.org/10.1002/eji.201444787.
Texto completoSantos, Rodrigo I., Philipp A. Ilinykh, Colette A. Pietzsch, Adam J. Ronk, Kai Huang, Natalia A. Kuzmina, Fuchun Zhou, James E. Crowe y Alexander Bukreyev. "Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin". Cell Reports 42, n.º 10 (octubre de 2023): 113254. http://dx.doi.org/10.1016/j.celrep.2023.113254.
Texto completoMatatall, Katie A., Hamilton Wang, Roman Jaksik, Marek Kimmel, Dongsu Park y Katherine Y. King. "A Novel Role for Bst2 and E-Selectin in IFNg-Stimulated HSC Niche Relocalization". Blood 132, Supplement 1 (29 de noviembre de 2018): 874. http://dx.doi.org/10.1182/blood-2018-99-116547.
Texto completoJaguva Vasudevan, Ananda Ayyappan, Daniel Becker, Tom Luedde, Holger Gohlke y Carsten Münk. "Foamy Viruses, Bet, and APOBEC3 Restriction". Viruses 13, n.º 3 (18 de marzo de 2021): 504. http://dx.doi.org/10.3390/v13030504.
Texto completoHammonds, Jason, Jaang-Jiun Wang, Hong Yi y Paul Spearman. "Immunoelectron Microscopic Evidence for Tetherin/BST2 as the Physical Bridge between HIV-1 Virions and the Plasma Membrane". PLoS Pathogens 6, n.º 2 (5 de febrero de 2010): e1000749. http://dx.doi.org/10.1371/journal.ppat.1000749.
Texto completoPaliwal, Daizy, Prashant Joshi y Subrat Kumar Panda. "Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non- coding RNA (lncRNA) BISPR". PLOS ONE 12, n.º 11 (1 de noviembre de 2017): e0187334. http://dx.doi.org/10.1371/journal.pone.0187334.
Texto completoSayeed, Aejaz, Gloria Luciani-Torres, Zhenhang Meng, James L. Bennington, Dan H. Moore y Shanaz H. Dairkee. "Aberrant Regulation of the BST2 (Tetherin) Promoter Enhances Cell Proliferation and Apoptosis Evasion in High Grade Breast Cancer Cells". PLoS ONE 8, n.º 6 (20 de junio de 2013): e67191. http://dx.doi.org/10.1371/journal.pone.0067191.
Texto completoGustin, Jean K., Ying Bai, Ashlee V. Moses y Janet L. Douglas. "Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin". Journal of Infectious Diseases 212, suppl 2 (27 de marzo de 2015): S181—S190. http://dx.doi.org/10.1093/infdis/jiv125.
Texto completoMadjo, Ursula, Olivier Leymarie, Stéphane Frémont, Aurelia Kuster, Mélanie Nehlich, Sarah Gallois-Montbrun, Katy Janvier y Clarisse Berlioz-Torrent. "LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway". Cell Reports 17, n.º 9 (noviembre de 2016): 2221–33. http://dx.doi.org/10.1016/j.celrep.2016.10.045.
Texto completoPham, T. N. Q., S. Lukhele y É. A. Cohen. "OA2-4 Enhancing HIV-1 virion tethering by BST2/tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies". Journal of Virus Eradication 2 (julio de 2016): 3. http://dx.doi.org/10.1016/s2055-6640(20)31011-6.
Texto completoMwimanzi, Philip, Ian Tietjen, Scott C. Miller, Aniqa Shahid, Kyle Cobarrubias, Natalie N. Kinloch, Bemuluyigza Baraki et al. "Novel Acylguanidine-Based Inhibitor of HIV-1". Journal of Virology 90, n.º 20 (10 de agosto de 2016): 9495–508. http://dx.doi.org/10.1128/jvi.01107-16.
Texto completoMurphy, Lita, Mariana Varela, Sophie Desloire, Najate Ftaich, Claudio Murgia, Matthew Golder, Stuart Neil et al. "The Sheep Tetherin Paralog oBST2B Blocks Envelope Glycoprotein Incorporation into Nascent Retroviral Virions". Journal of Virology 89, n.º 1 (22 de octubre de 2014): 535–44. http://dx.doi.org/10.1128/jvi.02751-14.
Texto completoTanwattana, Nathiphat, Nanchaya Wanasen, Yuparat Jantraphakorn, Kanjana Srisutthisamphan, Thanathom Chailungkarn, Suwimon Boonrungsiman, Boonlert Lumlertdacha, Porntippa Lekchareonsuk y Challika Kaewborisuth. "Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation". PLOS ONE 18, n.º 11 (3 de noviembre de 2023): e0292833. http://dx.doi.org/10.1371/journal.pone.0292833.
Texto completoZhao, Yifei, Ke Zhao, Shaohua Wang y Juan Du. "Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1". Frontiers in Cellular and Infection Microbiology 12 (13 de septiembre de 2022). http://dx.doi.org/10.3389/fcimb.2022.979091.
Texto completoJia, Xiaofei, Erin Weber, Andrey Tokarev, Mary Lewinski, Maryan Rizk, Marissa Suarez, John Guatelli y Yong Xiong. "Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1". eLife 3 (29 de abril de 2014). http://dx.doi.org/10.7554/elife.02362.
Texto completoJudith, Delphine, Margaux Versapuech, Fabienne Bejjani, Marjory Palaric, Pauline Verlhac, Aurelia Kuster, Leslie Lepont, Sarah Gallois-Montbrun, Katy Janvier y Clarisse Berlioz-Torrent. "ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway". Proceedings of the National Academy of Sciences 120, n.º 20 (8 de mayo de 2023). http://dx.doi.org/10.1073/pnas.2217451120.
Texto completoDolskiy, Alexander A., Sergei A. Bodnev, Anastasia A. Nazarenko, Anastasia M. Smirnova, Olga G. Pyankova, Anna K. Matveeva, Irina V. Grishchenko et al. "Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line". Frontiers in Molecular Biosciences 7 (18 de diciembre de 2020). http://dx.doi.org/10.3389/fmolb.2020.616798.
Texto completoBotticelli, S., R. Chiaraluce, V. Consalvi, G. La Penna, A. Pasquo, M. Petrosino, O. Proux, G. C. Rossi, F. Stellato y S. Morante. "The role of Zn ions in the interaction between SARS-CoV-2 orf7a protein and BST2/tetherin". European Physical Journal Plus 138, n.º 3 (8 de marzo de 2023). http://dx.doi.org/10.1140/epjp/s13360-023-03731-w.
Texto completoLiberatore, Rachel A., Emily J. Mastrocola, Chelsea Powell y Paul D. Bieniasz. "Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis". Journal of Virology 91, n.º 12 (5 de abril de 2017). http://dx.doi.org/10.1128/jvi.02286-16.
Texto completoRizk, Maryan G., Christopher F. Basler y John Guatelli. "Cooperation of the Ebola Virus Proteins VP40 and GP1,2 with BST2 To Activate NF-κB Independently of Virus-Like Particle Trapping". Journal of Virology 91, n.º 22 (6 de septiembre de 2017). http://dx.doi.org/10.1128/jvi.01308-17.
Texto completoBarriocanal, Marina, Elena Carnero, Victor Segura y Puri Fortes. "Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin". Frontiers in Immunology 5 (9 de enero de 2015). http://dx.doi.org/10.3389/fimmu.2014.00655.
Texto completoOhAinle, Molly, Louisa Helms, Jolien Vermeire, Ferdinand Roesch, Daryl Humes, Ryan Basom, Jeffrey J. Delrow, Julie Overbaugh y Michael Emerman. "A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV". eLife 7 (6 de diciembre de 2018). http://dx.doi.org/10.7554/elife.39823.
Texto completoShi, Yuhang, Sergio Castro-Gonzalez, Yuexuan Chen y Ruth Serra-Moreno. "Effects of the SUMO Ligase BCA2 on Metabolic Activity, Cell Proliferation, Cell Migration, Cell Cycle, and the Regulation of NF-κB and IRF1 in Different Breast Epithelial Cellular Contexts". Frontiers in Cell and Developmental Biology 9 (13 de septiembre de 2021). http://dx.doi.org/10.3389/fcell.2021.711481.
Texto completo